首页> 外国专利> COMPOUNDS FOR INHIBITION OF CHYMOTRYPSIN-LIKE ACTIVITY OF THE 20S PROTEASOME

COMPOUNDS FOR INHIBITION OF CHYMOTRYPSIN-LIKE ACTIVITY OF THE 20S PROTEASOME

机译:抑制20S蛋白质类胰蛋白酶样活性的化合物

摘要

Peptide-based compounds including heteroatom-containing, three-membered ringsefficiently and selectively inhibit specific activities of N-terminalnucleophile (Ntn) hydrolases. The activities of those Ntn having multipleactivities can be differentially inhibited by the compounds described. Forexample, the chymotrypsin-like activity of the 20S proteasome may beselectively inhibited with the inventive compounds. The peptide-basedcompounds include an epoxide or aziridine, and functionalization at the N-terminus. Among other therapeutic utilities, the peptide-based compounds areexpected to display anti-inflammatory properties and inhibition of cellproliferation.
机译:基于肽的化合物,包括含杂原子的三元环有效和选择性地抑制N末端的特定活性亲核试剂(Ntn)水解酶。那些Ntn具有多个活动所述化合物可以不同地抑制其活性。对于例如,20S蛋白酶体的胰凝乳蛋白酶样活性可能是被本发明化合物选择性抑制。基于肽化合物包括环氧化物或氮丙啶,并在N-总站。在其他治疗用途中,基于肽的化合物为有望显示出抗炎特性并抑制细胞增殖。

著录项

  • 公开/公告号CA2589765A1

    专利类型

  • 公开/公告日2006-02-16

    原文格式PDF

  • 申请/专利权人 PROTEOLIX INC.;

    申请/专利号CA20052589765

  • 发明设计人 SMYTH MARK S.;LAIDIG GUY J.;

    申请日2005-08-08

  • 分类号C07K5/087;A61K38/06;A61K38/07;C07K5/02;C07K5/103;

  • 国家 CA

  • 入库时间 2022-08-21 21:34:59

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号